Search
Showing 4384 results
Battle Over Nifty Futures & Options
On Feb. 9, India’s three main stock exchanges issued a statement saying they will stop licensing their stock indexes and market data to foreign exchanges and index providers in order to curtail offshore trading of equity index derivatives based in Indian stocks.
CONTINUE READINGA Trader's Perspective on the Post-Crisis Reforms
As global head of trading at Eaton Vance, Michael O'Brien has a front row seat on the changes in financial markets over the past decade.
CONTINUE READING2017 Annual Volume Survey
At the highest level, 2017 looks like an unexceptional year in the global exchange traded derivatives markets.
CONTINUE READINGVendor Consolidation
On Nov. 28, Sweden's Itiviti and France's Ullink announced plans to merge their technology and market infrastructure businesses.
CONTINUE READINGTrading Technologies places a bet on artificial intelligence
Trading Technologies International, a leading independent provider of software for trading futures, has acquired Neurensic, a compliance firm that uses artificial intelligence to sniff out trading irregularities in close to real time.
CONTINUE READINGTechnology-Neutral Regulation
On Nov. 14, five U.S. financial associations including FIA asked the Securities and Exchange Commission to update its broker-dealer electronic retention Rule 17a-4 by eliminating an obsolete recordkeeping requirement known as WORM (write once, read many) that was first put in place more than 20 years ago.
CONTINUE READINGSwap Dealer Registration Relief
On Oct. 26, the Commodity Futures Trading Commission issued an order that will keep the swap dealer de minimis threshold at $8 billion until December 2019.
CONTINUE READINGSwap Clearing in China
On Nov. 20, the Commodity Futures Trading Commission extended no-action relief for Shanghai Clearing House until the earlier of February 2018 or the date on which SCH receives exemption from registration as a derivatives clearing organization.
CONTINUE READINGRide for Beth: Raising money for research into scleroderma
James Egan works for ABN Amro Clearing Bank as the chief commercial officer for Europe. In 2015 his 11-year-old daughter Beth was diagnosed with a type of auto-immune disease called scleroderma.
CONTINUE READINGResearch Unbundling
On Dec. 11, the Commodity Futures Trading Commission issued interpretative guidance addressing a potential compliance issue for intermediaries that do business with investment managers in Europe.
CONTINUE READING